Flywheel and AIQ Solutions recently announced a partnership to offer a data management and analysis solution to increase clinicians’ and researchers’ understanding of treatment response for complex diseases that include the largest research area of oncology. The combination of Flywheel’s cloud-scale data management and collaboration platform along with the powerful AIQ technology will provide a scalable solution for improved patient management and the overall delivery of accurate data for the therapeutic area.


AIQ's software has been cleared for clinical use under 510(k) K173444. For details, including the applicable Indications for Use,
see: https://www.accessdata.fda.gov/scripts/cdrh/cfcodes/cfPMN/pmn.cfm?ID=K173444